CRISPR Inhibition of Essential Peptidoglycan Biosynthesis Genes in Mycobacterium abscessus and Its Impact on b-Lactam Susceptibility

Natalia Kurepina, Liang Chen, Kaelea Composto, Dalin Rifat, Eric L. Nuermberger, Barry N. Kreiswirth

Research output: Contribution to journalArticlepeer-review

Abstract

We utilized a CRISPR interference (CRISPRi) assay to control the gene expressions of two predicted essential peptidoglycan biosynthesis genes, pbpB and cwIM, in Mycobacterium abscessus and to evaluate their contribution to b-lactam susceptibility. Our results showed that CRISPR inhibition of each gene led to a significant 3-log10 reduction in CFU in the presence of imipenem but not for cefoxitin. These results demonstrate that CRISPRi provides an experimental approach to study drug/ target interactions in M. abscessus.

Original languageEnglish (US)
JournalAntimicrobial agents and chemotherapy
Volume66
Issue number4
DOIs
StatePublished - Apr 2022

Keywords

  • CRISPRi
  • Mycobacterium abscessus
  • b-lactam
  • peptidoglycan biosynthesis

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases
  • Pharmacology

Fingerprint

Dive into the research topics of 'CRISPR Inhibition of Essential Peptidoglycan Biosynthesis Genes in Mycobacterium abscessus and Its Impact on b-Lactam Susceptibility'. Together they form a unique fingerprint.

Cite this